Literature DB >> 25141794

Structure and hypolipidaemic activity of fucoidan extracted from brown seaweed Sargassum henslowianum.

Ho Duc Cuong1, Thanh Thi Thu Thuy, Tran Thu Huong, Bui Minh Ly, Tran Thi Thanh Van.   

Abstract

The aim of this study is to elucidate the structure and investigate the hypolipidaemic activity of a fucoidan extracted from brown seaweed Sargassum henslowianum collected at Hai Van-Son Cha peninsula, Hue province, Vietnam by using tandem electrospray ionisation mass spectrometry. The results demonstrated that the fucoidan has α(1 → 3)-linked L-fucopyranose backbone and sulphate groups occupied mostly at C-2, C-4 and sometimes at C-3 position of fucose residues. The results of in vivo bioactivity examination revealed that the fucoidan in the dose of 100 mg/kgP/day by oral administration helped decrease cholesterol, triglyceride and LDL-cholesterol levels on obese mice.

Entities:  

Keywords:  Fucoidan; brown seaweed Sargassum henslowianum; hypolipidaemic activity; structure

Mesh:

Substances:

Year:  2014        PMID: 25141794     DOI: 10.1080/14786419.2014.948436

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  9 in total

Review 1.  Fucoidan Characterization: Determination of Purity and Physicochemical and Chemical Properties.

Authors:  Ahmed Zayed; Mona El-Aasr; Abdel-Rahim S Ibrahim; Roland Ulber
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

Review 2.  Brown Algae Potential as a Functional Food against Hypercholesterolemia: Review.

Authors:  Rebeca André; Rita Pacheco; Mafalda Bourbon; Maria Luísa Serralheiro
Journal:  Foods       Date:  2021-01-24

Review 3.  Pharmacological Activities of Sulfated Fucose-Rich Polysaccharides after Oral Administration: Perspectives for the Development of New Carbohydrate-Based Drugs.

Authors:  Roberto J C Fonseca; Paulo A S Mourão
Journal:  Mar Drugs       Date:  2021-07-27       Impact factor: 5.118

Review 4.  Application of fucoidan as treatment for cardiovascular and cerebrovascular diseases.

Authors:  Ke Wang; Xueli Xu; Qiang Wei; Qiong Yang; Jiarui Zhao; Yuan Wang; Xia Li; Kai Ji; Shuliang Song
Journal:  Ther Adv Chronic Dis       Date:  2022-04-12       Impact factor: 5.091

Review 5.  Pharmacological and natural products diversity of the brown algae genus Sargassum.

Authors:  Mohammed I Rushdi; Iman A M Abdel-Rahman; Hani Saber; Eman Zekry Attia; Wedad M Abdelraheem; Hashem A Madkour; Hossam M Hassan; Abeer H Elmaidomy; Usama Ramadan Abdelmohsen
Journal:  RSC Adv       Date:  2020-07-01       Impact factor: 4.036

Review 6.  Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods.

Authors:  Susana M Cardoso; Olívia R Pereira; Ana M L Seca; Diana C G A Pinto; Artur M S Silva
Journal:  Mar Drugs       Date:  2015-11-12       Impact factor: 5.118

Review 7.  Marine Algae as a Potential Source for Anti-Obesity Agents.

Authors:  Chu Wan-Loy; Phang Siew-Moi
Journal:  Mar Drugs       Date:  2016-12-07       Impact factor: 5.118

8.  Water Extraction Kinetics of Bioactive Compounds of Fucus vesiculosus.

Authors:  Ricardo M Ferreira; Ana Ramalho Ribeiro; Carla Patinha; Artur M S Silva; Susana M Cardoso; Rui Costa
Journal:  Molecules       Date:  2019-09-19       Impact factor: 4.411

Review 9.  Seaweeds and Their Natural Products for Preventing Cardiovascular Associated Dysfunction.

Authors:  Bomi Ryu; Young-Sang Kim; You-Jin Jeon
Journal:  Mar Drugs       Date:  2021-09-07       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.